Yeah but MSB has to prove the cells work.
Don't forget, the last back pain trial failed the primary endpoint.
And if you had any clinical experience with chronic back pain you would understand why one Mmmm I am so skeptical that MSB would have some silver bullet.
I guarantee, those pharmaceutical companies understand the issue even better than me.
2024 Here we go again., page-114
-
- There are more pages in this discussion • 830 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |